Trial · NCT01290549
Registered outcomes27
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
21 to 27 of 27
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Secondary | Volume of Distribution at Steady State-Polatuzumab Vedotin Combined with Rituximab | Pre infusion (0 hour) and 0.5 hours post infusion (duration of infusion: 90 minutes for first infusion and 30 minutes for subsequent infusions) on Cycle 1 Day 1; Cycle 1 Days 2, 4, 8, 11 and 15 (cycle length: 21 days) | |
| Secondary | AUClast of Rituximab When Given in Combination With Polatuzumab Vedotin | Pre rituximab (0 hour) dose and 30 minutes post rituximab dose on Cycle 1 Day 1; Cycle 1 Days 4, 8, 15 (cycle length: 21 days) | |
| Secondary | AUCinf of Rituximab When Given in Combination With Polatuzumab Vedotin | Pre rituximab (0 hour) dose and 30 minutes post rituximab dose on Cycle 1 Day 1; Cycle 1 Days 4, 8, 15 (cycle length: 21 days) | |
| Secondary | AUCextrap of Rituximab When Given in Combination With Polatuzumab Vedotin | Pre rituximab (0 hour) dose and 30 minutes post rituximab dose on Cycle 1 Day 1; Cycle 1 Days 4, 8, 15 (cycle length: 21 days) | |
| Secondary | Cmax of Rituximab When Given in Combination With Polatuzumab Vedotin | Pre rituximab (0 hour) dose and 30 minutes post rituximab dose on Cycle 1 Day 1; Cycle 1 Days 4, 8, 15 (cycle length: 21 days) | |
| Secondary | Clearance of Rituximab When Given in Combination With Polatuzumab Vedotin | Pre rituximab (0 hour) dose and 30 minutes post rituximab dose on Cycle 1 Day 1; Cycle 1 Days 4, 8, 15 (cycle length: 21 days) | |
| Secondary | Volume of Distribution at Steady State-of Rituximab When Given in Combination With Polatuzumab Vedotin | Pre rituximab (0 hour) dose and 30 minutes post rituximab dose on Cycle 1 Day 1; Cycle 1 Days 4, 8, 15 (cycle length: 21 days) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01290549/registered?page=2